Ascendis Pharma A/S (ASND)
USD 172.06
(2.74%)
USD 172.06
(2.74%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 677.86 Million EUR | 12.82% |
| 2022 | 600.85 Million EUR | 31.75% |
| 2021 | 456.04 Million EUR | 35.1% |
| 2020 | 337.57 Million EUR | 40.6% |
| 2019 | 240.09 Million EUR | 45.21% |
| 2018 | 165.33 Million EUR | 46.22% |
| 2017 | 113.07 Million EUR | 45.85% |
| 2016 | 77.52 Million EUR | 55.23% |
| 2015 | 49.94 Million EUR | 92.3% |
| 2014 | 25.97 Million EUR | 71.67% |
| 2013 | 15.12 Million EUR | 7.53% |
| 2012 | 14.07 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 137.47 Million EUR | -11.23% |
| 2024 Q2 | 156.59 Million EUR | 14.78% |
| 2023 Q4 | 154.85 Million EUR | -11.54% |
| 2023 FY | 677.86 Million EUR | 12.82% |
| 2023 Q1 | 172.65 Million EUR | 4.53% |
| 2023 Q2 | 175.3 Million EUR | 1.53% |
| 2023 Q3 | 175.05 Million EUR | -0.14% |
| 2022 Q4 | 165.17 Million EUR | 4.47% |
| 2022 Q3 | 158.1 Million EUR | 7.58% |
| 2022 Q1 | 130.61 Million EUR | 14.62% |
| 2022 Q2 | 146.96 Million EUR | 12.52% |
| 2022 FY | 600.85 Million EUR | 31.75% |
| 2021 Q3 | 98.04 Million EUR | -17.37% |
| 2021 FY | 456.04 Million EUR | 35.1% |
| 2021 Q2 | 118.65 Million EUR | -5.38% |
| 2021 Q1 | 125.39 Million EUR | 30.38% |
| 2021 Q4 | 113.95 Million EUR | 16.23% |
| 2020 Q3 | 81.58 Million EUR | -3.32% |
| 2020 Q4 | 96.17 Million EUR | 17.89% |
| 2020 FY | 337.57 Million EUR | 40.6% |
| 2020 Q2 | 84.38 Million EUR | 11.87% |
| 2020 Q1 | 75.43 Million EUR | 11.99% |
| 2019 Q1 | 61.69 Million EUR | 33.06% |
| 2019 FY | 240.09 Million EUR | 45.21% |
| 2019 Q4 | 67.35 Million EUR | 19.73% |
| 2019 Q3 | 56.25 Million EUR | 2.69% |
| 2019 Q2 | 54.78 Million EUR | -11.2% |
| 2018 FY | 165.33 Million EUR | 46.22% |
| 2018 Q4 | 46.36 Million EUR | 21.04% |
| 2018 Q2 | 45.46 Million EUR | 29.14% |
| 2018 Q1 | 35.2 Million EUR | 9.6% |
| 2018 Q3 | 38.3 Million EUR | -15.74% |
| 2017 Q3 | 31.9 Million EUR | 27.06% |
| 2017 FY | 113.07 Million EUR | 45.85% |
| 2017 Q1 | 23.93 Million EUR | 2.82% |
| 2017 Q2 | 25.11 Million EUR | 4.92% |
| 2017 Q4 | 32.12 Million EUR | 0.67% |
| 2016 Q4 | 23.27 Million EUR | 21.54% |
| 2016 FY | 77.52 Million EUR | 55.23% |
| 2016 Q1 | 19.15 Million EUR | 19.8% |
| 2016 Q3 | 19.15 Million EUR | 20.08% |
| 2016 Q2 | 15.94 Million EUR | -16.72% |
| 2015 Q1 | 9.73 Million EUR | -1.5% |
| 2015 Q4 | 15.98 Million EUR | 69.44% |
| 2015 Q3 | 9.43 Million EUR | -36.19% |
| 2015 Q2 | 14.78 Million EUR | 51.81% |
| 2015 FY | 49.94 Million EUR | 92.3% |
| 2014 Q1 | 4.5 Million EUR | 37.4% |
| 2014 Q3 | 5.48 Million EUR | -9.93% |
| 2014 Q2 | 6.09 Million EUR | 35.28% |
| 2014 FY | 25.97 Million EUR | 71.67% |
| 2014 Q4 | 9.88 Million EUR | 80.16% |
| 2013 Q3 | 4.52 Million EUR | 20.24% |
| 2013 Q1 | 3.76 Million EUR | 0.0% |
| 2013 FY | 15.12 Million EUR | 7.53% |
| 2013 Q4 | 3.27 Million EUR | -27.57% |
| 2013 Q2 | 3.76 Million EUR | 0.0% |
| 2012 FY | 14.07 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Absci Corporation | 73.66 Million USD | -820.186% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -110.675% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 62.342% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -6721.173% |
| Apollomics, Inc. | 54.14 Million USD | -1152.058% |
| 180 Life Sciences Corp. | 13.47 Million USD | -4929.597% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -2060.385% |
| Bicycle Therapeutics plc | 216.92 Million USD | -212.492% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -700.161% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -294.332% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -1342.08% |
| Chimerix, Inc. | 93.38 Million USD | -625.85% |
| CRISPR Therapeutics AG | 463.49 Million USD | -46.251% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -1909.796% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -482.092% |
| Fortress Biotech, Inc. | 200.19 Million USD | -238.602% |
| Fortress Biotech, Inc. | 200.19 Million USD | -238.602% |
| Gritstone bio, Inc. | 148.37 Million USD | -356.862% |
| Allakos Inc. | 196.05 Million USD | -245.75% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -1137.068% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -375.818% |
| Cytokinetics, Incorporated | 173.61 Million USD | -290.448% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -2518.752% |
| Innoviva, Inc. | 132.15 Million USD | -412.935% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -8712.307% |
| NLS Pharmaceutics AG | 11.8 Million USD | -5641.174% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -433.491% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -5257104.902% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -560.957% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -662.793% |
| ImmuCell Corporation | 9.61 Million USD | -6948.336% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -329.534% |
| Incyte Corporation | 1.19 Billion USD | 43.06% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -411.383% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -9974.174% |
| Mustang Bio, Inc. | 48.5 Million USD | -1297.629% |
| MiMedx Group, Inc. | 229.72 Million USD | -195.074% |
| MEI Pharma, Inc. | 34.78 Million USD | -1848.725% |
| MacroGenics, Inc. | 217.21 Million USD | -212.071% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -7575.755% |
| Mereo BioPharma Group plc | 35.84 Million USD | -1791.256% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -3688.535% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -322.24% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -294.451% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -2835.926% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -4167.053% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -6490.802% |
| NextCure, Inc. | 67.63 Million USD | -902.209% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -1153.447% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -2189.617% |
| Onconetix, Inc. | 34.9 Million USD | -1841.89% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -5218.249% |
| Opthea Limited | 191.96 Million USD | -253.114% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -1035.961% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -24535.401% |
| PDS Biotechnology Corporation | 43.04 Million USD | -1474.771% |
| Precigen, Inc. | 84.18 Million USD | -705.246% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -834.134% |
| Prime Medicine, Inc. | 186.63 Million USD | -263.195% |
| PureTech Health plc | 144.59 Million USD | -368.795% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -161.059% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 75.922% |
| Replimune Group, Inc. | 234.77 Million USD | -188.732% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -7730.545% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -420.381% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -3390.813% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -35.908% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -2688.805% |
| Sesen Bio, Inc. | 78.38 Million USD | -764.832% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -196.425% |
| Solid Biosciences Inc. | 104.31 Million USD | -549.824% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -194.782% |
| SciSparc Ltd. | 9.01 Million USD | -7422.628% |
| Sutro Biopharma, Inc. | 243 Million USD | -178.946% |
| TG Therapeutics, Inc. | 198.47 Million USD | -241.536% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -458.34% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -8985.431% |
| Travere Therapeutics, Inc. | 472 Million USD | -43.615% |
| UroGen Pharma Ltd. | 138.88 Million USD | -388.065% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -860.229% |
| XOMA Corporation | 46.46 Million USD | -1358.933% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -168.406% |
| AbCellera Biologics Inc. | 275.23 Million USD | -146.288% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -1094.285% |
| Cassava Sciences, Inc. | 105.95 Million USD | -539.754% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -4773.339% |
| Precision BioSciences, Inc. | 92.46 Million USD | -633.119% |
| Dyadic International, Inc. | 9.15 Million USD | -7306.168% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -8048.383% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -2946.169% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -2183.754% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -416.692% |
| IGM Biosciences, Inc. | 265.59 Million USD | -155.229% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -530.442% |
| Acelyrin, Inc. | 422.06 Million USD | -60.607% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -3678.717% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -703.89% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -9969.365% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -176.675% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -2102.931% |
| Senti Biosciences, Inc. | 94.7 Million USD | -615.764% |
| Mesoblast Limited | 5.9 Million USD | -11385.327% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -177.674% |
| ChromaDex Corporation | 56.37 Million USD | -1102.334% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -1933.791% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -237.053% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -8329.146% |
| Seer, Inc. | 110.49 Million USD | -513.507% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -302.446% |
| Novavax, Inc. | 779.12 Million USD | 12.997% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -4220.415% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -166.829% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -1197.323% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -174.286% |
| Celcuity Inc. | 66.23 Million USD | -923.495% |
| ContextLogic Inc. | 387 Million USD | -75.159% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -303.906% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -1970.067% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 79.179% |
| Amarin Corporation plc | 272.35 Million USD | -148.888% |
| AnaptysBio, Inc. | 181.56 Million USD | -273.339% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -2247.337% |
| Aptorum Group Limited | 10.56 Thousand USD | -6415421.484% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -511.421% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -52.077% |
| Ardelyx, Inc. | 169.93 Million USD | -298.891% |
| Celularity Inc. | 215.05 Million USD | -215.201% |
| Omeros Corporation | 94.75 Million USD | -615.416% |
| Humacyte, Inc. | 23.49 Million USD | -2784.896% |
| Immunocore Holdings plc | 308.04 Million USD | -120.057% |
| IO Biotech, Inc. | 91.44 Million USD | -641.297% |
| GT Biopharma, Inc. | 13.57 Million USD | -4893.105% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -807.935% |
| Summit Therapeutics Inc. | 87.68 Million USD | -673.058% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -2200.261% |
| Pulmatrix, Inc. | 22.03 Million USD | -2975.887% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -22.898% |
| Evogene Ltd. | 27.79 Million USD | -2339.237% |
| CorMedix Inc. | 48.95 Million USD | -1284.589% |
| BioLineRx Ltd. | 50.8 Million USD | -1234.325% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -1888.746% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -1970.446% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | 48.327% |
| scPharmaceuticals Inc. | 65.17 Million USD | -940.02% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -497.4% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -83.896% |
| NLS Pharmaceutics AG | 11.8 Million USD | -5641.174% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -2688.805% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -292.124% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -1712.083% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -2536.782% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -448.642% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -716.182% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -1175.946% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -7919.463% |
| Daré Bioscience, Inc. | 33.6 Million USD | -1916.888% |
| bluebird bio, Inc. | 240.23 Million USD | -182.171% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 61.182% |
| DBV Technologies S.A. | 92.16 Million USD | -635.53% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -176.501% |
| Galecto, Inc. | 35.62 Million USD | -1802.669% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -1728.901% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -991.885% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -208.358% |
| GlycoMimetics, Inc. | 39.28 Million USD | -1625.491% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -129.225% |
| ADMA Biologics, Inc. | 66.58 Million USD | -918.028% |
| Clene Inc. | 41.07 Million USD | -1550.388% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -92.549% |
| Aptose Biosciences Inc. | 52.35 Million USD | -1194.721% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -4604.0% |
| Soligenix, Inc. | 7.79 Million USD | -8595.859% |
| Century Therapeutics, Inc. | 56.07 Million USD | -1108.939% |
| Kura Oncology, Inc. | 165.8 Million USD | -308.835% |
| Surrozen, Inc. | 18.55 Million USD | -3554.253% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -491.985% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -27215.174% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -529.412% |
| Autolus Therapeutics plc | 196.72 Million USD | -244.573% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -700.718% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -3397.209% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -350.3% |
| GRI Bio, Inc. | 11.33 Million USD | -5882.913% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -9507.323% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -736.229% |
| INmune Bio, Inc. | 29.89 Million USD | -2167.407% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -292.842% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -1581.448% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -4142.122% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -8132.558% |
| Jaguar Health, Inc. | 42.01 Million USD | -1513.386% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -4206.208% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -991.604% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -1972.028% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -145.876% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -124.867% |
| Verastem, Inc. | 92.08 Million USD | -636.137% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -264.983% |
| Histogen Inc. | 14.27 Million USD | -4649.608% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -4123.941% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | 10.108% |
| Surrozen, Inc. | 18.55 Million USD | -3554.253% |
| Organovo Holdings, Inc. | 14.91 Million USD | -4444.847% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -13216.946% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -8780.885% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -280.532% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -1299.159% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -4311.289% |
| Kronos Bio, Inc. | 128.11 Million USD | -429.093% |
| Turnstone Biologics Corp. | 78.33 Million USD | -765.307% |
| Synaptogenix, Inc. | 8.31 Million USD | -8053.427% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -4547.36% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -412.853% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -167.871% |
| Exelixis, Inc. | 1.58 Billion USD | 57.28% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -192.12% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | 20.736% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -884.395% |
| ESSA Pharma Inc. | 32.13 Million USD | -2009.485% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -4043.368% |
| Avid Bioservices, Inc. | 25.99 Million USD | -2507.57% |
| Insmed Incorporated | 949.26 Million USD | 28.59% |
| MediWound Ltd. | 18.86 Million USD | -3492.665% |
| OmniAb, Inc. | 83.89 Million USD | -707.991% |
| Alector, Inc. | 248.8 Million USD | -172.451% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -189.305% |
| Zai Lab Limited | 547.47 Million USD | -23.816% |
| AlloVir, Inc. | 180.93 Million USD | -274.649% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -70.038% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -511.901% |
| Aura Biosciences, Inc. | 84.99 Million USD | -697.572% |
| Immunic, Inc. | 99.22 Million USD | -583.172% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -326.297% |
| Veracyte, Inc. | 357.93 Million USD | -89.383% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 92.481% |
| FibroGen, Inc. | 398.11 Million USD | -70.269% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -4670.331% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -161.295% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -9741.307% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -9412.903% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -2519.967% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -114.146% |
| Fortrea Holdings Inc. | 457.3 Million USD | -48.232% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -1148.874% |
| XBiotech Inc. | 37.51 Million USD | -1707.155% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -884.395% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -300.447% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -1690.024% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -3182.793% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -377.164% |
| Agenus Inc. | 78.18 Million USD | -767.022% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -584.193% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -512.255% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | 29.26% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -2250.023% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -57.409% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -2938.616% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -324.23% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -12155.838% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -2562.571% |
| Lantern Pharma Inc. | 17.87 Million USD | -3691.701% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -1476.428% |
| Ainos, Inc. | 12.95 Million USD | -5133.395% |
| Pluri Inc. | 22.48 Million USD | -2915.409% |
| Prothena Corporation plc | 282.4 Million USD | -140.032% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -238.895% |
| Rallybio Corporation | 78.93 Million USD | -758.795% |
| Kodiak Sciences Inc. | 277.32 Million USD | -144.433% |
| Cue Biopharma, Inc. | 19.54 Million USD | -3368.754% |
| MeiraGTx Holdings plc | 151.07 Million USD | -348.685% |
| Annexon, Inc. | 143.72 Million USD | -371.646% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -2858.942% |
| Moderna, Inc. | 6.39 Billion USD | 89.398% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -19895.988% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -680.365% |
| Blueprint Medicines Corporation | 722.86 Million USD | 6.225% |
| Immix Biopharma, Inc. | 16.14 Million USD | -4099.611% |
| CalciMedica, Inc. | 21.81 Million USD | -3007.045% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -373.002% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -295.729% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -273.889% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -129.831% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -1860.561% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -834.328% |
| Nutriband Inc. | 5.73 Million USD | -11721.771% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -1454.271% |
| Vor Biopharma Inc. | 126.03 Million USD | -437.834% |
| Roivant Sciences Ltd. | 1.18 Billion USD | 42.997% |
| Alkermes plc | 996.24 Million USD | 31.958% |
| ProKidney Corp. | 151.52 Million USD | -347.37% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -813.871% |
| Arcellx, Inc. | 200.19 Million USD | -238.595% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -10.361% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -349.81% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -1680.479% |
| Atai Life Sciences N.V. | 125.78 Million USD | -438.907% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -730.316% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -732.665% |
| MediciNova, Inc. | 10.9 Million USD | -6118.785% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -426.21% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -9237.582% |
| GeoVax Labs, Inc. | 6.02 Million USD | -11156.136% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -42.301% |
| Biomea Fusion, Inc. | 126.13 Million USD | -437.412% |
| RenovoRx, Inc. | 11.39 Million USD | -5848.263% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -254.737% |
| Geron Corporation | 70.44 Million USD | -862.315% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -2357.632% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -407.421% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -179.922% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -158.679% |
| Royalty Pharma plc | 862.4 Million USD | 21.398% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -225.906% |
| Imunon, Inc. | 20.31 Million USD | -3237.518% |
| BioAtla, Inc. | 129.68 Million USD | -422.692% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -698.257% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -1523.315% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -226.191% |
| Structure Therapeutics Inc. | 102.77 Million USD | -559.561% |
| 89bio, Inc. | 151.2 Million USD | -348.311% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -509.749% |
| aTyr Pharma, Inc. | 12.97 Million USD | -5122.775% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -553.955% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -166.075% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -8141.694% |
| Akari Therapeutics, Plc | 16.8 Million USD | -3933.464% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -29709.716% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -126.47% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -292.126% |
| Liquidia Corporation | 87.98 Million USD | -670.44% |
| Entera Bio Ltd. | 8.86 Million USD | -7550.835% |
| GH Research PLC | 41.22 Million USD | -1544.423% |
| Vericel Corporation | 142.04 Million USD | -377.235% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -2906.849% |
| Xencor, Inc. | 306.97 Million USD | -120.819% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -13639.727% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -4142.122% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -3208.286% |
| Vaxcyte, Inc. | 468.04 Million USD | -44.83% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -1356.457% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -253.43% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -9974.174% |
| Portage Biotech Inc. | 18.19 Million USD | -3624.732% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -9237.582% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -545.825% |
| OncoCyte Corporation | 25.63 Million USD | -2544.085% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -11020.533% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -5816.561% |
| Purple Biotech Ltd. | -22.46 Million USD | 3117.154% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -2224.876% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -2096.649% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -168.479% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -4013.252% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -2187.685% |
| United Therapeutics Corporation | 885.1 Million USD | 23.414% |
| HilleVax, Inc. | 133.34 Million USD | -408.354% |
| Silo Pharma, Inc. | 3.92 Million USD | -17184.265% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -17095.732% |
| Pharming Group N.V. | 225.49 Million USD | -200.617% |
| Tharimmune, Inc. | 9.45 Million USD | -7069.204% |
| Genprex, Inc. | 31.06 Million USD | -2082.394% |
| Apogee Therapeutics, Inc. | 93 Million USD | -628.863% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -261.477% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -724.692% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -88509.673% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -12344.907% |
| OKYO Pharma Limited | 8243.57 USD | -8222842.245% |
| Savara Inc. | 15.74 Million USD | -4205.265% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -3783.05% |
| Curis, Inc. | 58.35 Million USD | -1061.621% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -13211.057% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -2408.563% |
| BeiGene, Ltd. | 3.28 Billion USD | 79.375% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -341.168% |
| Erasca, Inc. | 141.52 Million USD | -378.971% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -14873.888% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -14873.888% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -1490.894% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -4618.53% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -916.273% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -1461.395% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -225.693% |
| Adicet Bio, Inc. | 152.03 Million USD | -345.852% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -58.509% |
| Aditxt, Inc. | 25.95 Million USD | -2512.116% |
| Adagene Inc. | 41.83 Million USD | -1520.469% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -9172.981% |
| Quantum-Si incorporated | 111.65 Million USD | -507.084% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -4549.985% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -1792.312% |
| Compugen Ltd. | 43.97 Million USD | -1441.616% |
| Generation Bio Co. | 144.46 Million USD | -369.217% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -716.409% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -684.02% |
| Invivyd, Inc. | 205.75 Million USD | -229.452% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -839.403% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -7127.848% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -800.768% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -6489.521% |
| 2seventy bio, Inc. | 289.88 Million USD | -133.837% |
| Instil Bio, Inc. | 85.78 Million USD | -690.189% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -5192.552% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -59645.809% |
| GeoVax Labs, Inc. | 6.02 Million USD | -11156.136% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -1745.431% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -553.665% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -298.093% |
| Vir Biotechnology, Inc. | 767.72 Million USD | 11.704% |
| Evaxion Biotech A/S | 22.27 Million USD | -2943.844% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -400.106% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -188.598% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -747.913% |
| Cingulate Inc. | 22.75 Million USD | -2878.419% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 9147.838% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -1417.595% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -992.026% |
| Clearmind Medicine Inc. | 8.74 Million USD | -7654.683% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -706.29% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -23011.745% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -572.304% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -78.153% |
| ImmunityBio, Inc. | 362.87 Million USD | -86.805% |
| Korro Bio, Inc. | 84.53 Million USD | -701.883% |
| Kineta, Inc. | 21.15 Million USD | -3104.122% |
| BioVie Inc. | 31.95 Million USD | -2021.626% |
| Codexis, Inc. | 66.51 Million USD | -919.069% |
| Celularity Inc. | 215.05 Million USD | -215.201% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -4064.807% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -199.118% |
| Virax Biolabs Group Limited | 6.54 Million USD | -10253.711% |
| Cibus, Inc. | 320.3 Million USD | -111.631% |
| IN8bio, Inc. | 30.33 Million USD | -2134.446% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -431.279% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -105816.25% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | 13.048% |
| Eyenovia, Inc. | 25.4 Million USD | -2568.079% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -383.102% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -12087.415% |
| Elevation Oncology, Inc. | 45.44 Million USD | -1391.614% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -756.614% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -1376.828% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -213.23% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -6707.914% |
| Moolec Science SA | 52.75 Million USD | -1185.035% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -1008.744% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -1356.519% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -620.58% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -1298.436% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -7167.086% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -2895.616% |
| Humacyte, Inc. | 23.49 Million USD | -2784.896% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -745.934% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -4562.063% |
| Genelux Corporation | 24.33 Million USD | -2685.552% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -1898.243% |
| Notable Labs, Ltd. | 14.77 Million USD | -4489.465% |
| Immunovant, Inc. | 282.7 Million USD | -139.774% |
| Quantum-Si incorporated | 111.65 Million USD | -507.084% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -3087.398% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -564.494% |
| Acasti Pharma Inc. | 11.3 Million USD | -5898.266% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -2857.379% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -1537.986% |
| PepGen Inc. | 84.76 Million USD | -699.689% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -2860.493% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -1971.361% |
| Immuneering Corporation | 58.41 Million USD | -1060.47% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -13216.946% |
| Belite Bio, Inc | 31.66 Million USD | -2040.533% |
| XOMA Corporation | 46.46 Million USD | -1358.933% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -903.5% |
| Bionomics Limited | 17.89 Billion USD | 96.211% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 1999.843% |
| uniQure N.V. | 285.08 Million USD | -137.775% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -9172.981% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -249.042% |
| Forte Biosciences, Inc. | 32.47 Million USD | -1987.213% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -8058.43% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -2206.052% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -12087.415% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -4670.331% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -7525.875% |
| Altimmune, Inc. | 30.55 Million USD | -2118.432% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -858.749% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 1999.843% |
| Peak Bio, Inc. | 1249.13 USD | -54266789.755% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -814.549% |
| Benitec Biopharma Inc. | 22.38 Million USD | -2928.612% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -178.74% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -2274.887% |
| Zura Bio Limited | 62.63 Million USD | -982.193% |
| PolyPid Ltd. | 21.04 Million USD | -3121.022% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -2274.887% |
| argenx SE | 1.53 Billion USD | 55.797% |
| Immunome, Inc. | 122.82 Million USD | -451.917% |
| Verona Pharma plc | 67.15 Million USD | -909.458% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -2518.752% |
| Shattuck Labs, Inc. | 93.61 Million USD | -624.105% |
| CervoMed Inc. | 14.95 Million USD | -4431.853% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -7833.801% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -1229.145% |
| Moolec Science SA | 52.75 Million USD | -1185.035% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -4021.145% |
| Design Therapeutics, Inc. | 78.19 Million USD | -766.945% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -678.787% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -5286.285% |
| Achilles Therapeutics plc | 75.25 Million USD | -800.756% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -23011.745% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -1118.019% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -1232.306% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -925.528% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -1152.449% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -1392.797% |
| Beam Therapeutics Inc. | 554.19 Million USD | -22.315% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -172.794% |
| AEON Biopharma, Inc. | 48.42 Million USD | -1299.707% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -625.159% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -711.531% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -5285.474% |
| NeurAxis, Inc. | 8.82 Million USD | -7584.488% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -50.305% |
| Lumos Pharma, Inc. | 38.66 Million USD | -1653.172% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -2457.742% |
| Palisade Bio, Inc. | 13.32 Million USD | -4989.069% |
| Nutriband Inc. | 5.73 Million USD | -11721.771% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -671.264% |
| Neurogene Inc. | 55.58 Million USD | -1119.553% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -7921.11% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -600.924% |
| Athira Pharma, Inc. | 125.46 Million USD | -440.277% |
| HCW Biologics Inc. | 21.02 Million USD | -3123.699% |
| XOMA Corporation | 46.46 Million USD | -1358.933% |
| Nektar Therapeutics | 190.9 Million USD | -255.083% |
| Arvinas, Inc. | 480 Million USD | -41.222% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -29709.716% |
| Merus N.V. | 200.49 Million USD | -238.097% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -555.86% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -1858.013% |
| Rezolute, Inc. | 70.38 Million USD | -863.053% |
| Clene Inc. | 41.07 Million USD | -1550.388% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -4038.749% |
| BeyondSpring Inc. | 24.86 Million USD | -2626.177% |
| Synlogic, Inc. | 58.53 Million USD | -1058.108% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -3688.643% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -14990.472% |
| Peak Bio, Inc. | 1249.13 USD | -54266789.755% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -1021.437% |
| Krystal Biotech, Inc. | 160.42 Million USD | -322.54% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -150.475% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -94.767% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -31330.116% |
| MannKind Corporation | 125.59 Million USD | -439.714% |
| Ikena Oncology, Inc. | 84.57 Million USD | -701.476% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -6926.682% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -656.536% |
| Gossamer Bio, Inc. | 183.75 Million USD | -268.888% |
| CohBar, Inc. | 12.38 Million USD | -5371.809% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -1236.377% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -2357.632% |
| Legend Biotech Corporation | 583.14 Million USD | -16.243% |
| Mural Oncology plc | 192.07 Million USD | -252.924% |
| Disc Medicine, Inc. | 91.12 Million USD | -643.884% |
| Champions Oncology, Inc. | 28.11 Million USD | -2311.469% |
| REGENXBIO Inc. | 321.15 Million USD | -111.069% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -12543.806% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -1115.769% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -1639.869% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -492.761% |
| Vaxart, Inc. | 90.72 Million USD | -647.155% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -7856.143% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -1484.013% |
| Cellectis S.A. | 97.32 Million USD | -596.531% |
| Longeveron Inc. | 21.25 Million USD | -3089.948% |
| Repare Therapeutics Inc. | 167.35 Million USD | -305.041% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | 50.187% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -796.112% |
| Revolution Medicines, Inc. | 498.76 Million USD | -35.908% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -10090.379% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -1442.212% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -808.787% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -873.453% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -6028.969% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 85.804% |
| Denali Therapeutics Inc. | 527.23 Million USD | -28.571% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -7730.545% |
| Veru Inc. | 101.34 Million USD | -568.847% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -2795.988% |
| Cingulate Inc. | 22.75 Million USD | -2878.419% |
| Passage Bio, Inc. | 108.38 Million USD | -525.399% |
| Context Therapeutics Inc. | 25.07 Million USD | -2603.603% |
| Exicure, Inc. | 14.07 Million USD | -4715.743% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -228.958% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -1465.47% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -7286.32% |
| Nuvalent, Inc. | 149.49 Million USD | -353.445% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -8303.028% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -553.993% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -3060.352% |
| OmniAb, Inc. | 83.89 Million USD | -707.991% |
| Anew Medical, Inc. | 1.3 Million USD | -52009.674% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -1968.929% |
| Lipocine Inc. | 15.08 Million USD | -4395.078% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -889.395% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -790.146% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -1581.448% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -490.253% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -2928.342% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -2.066% |
| Ocugen, Inc. | 71.56 Million USD | -847.174% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -622.161% |
| Q32 Bio Inc. | 92.68 Million USD | -631.403% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -3101.398% |
| Alumis Inc. Common Stock | 158.17 Million USD | -328.556% |
| Equillium, Inc. | 50.6 Million USD | -1239.493% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -986.216% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -4774.771% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -3493.216% |
| Dominari Holdings Inc. | 23.83 Million USD | -2743.986% |
| Edesa Biotech, Inc. | 9.22 Million USD | -7249.906% |
| vTv Therapeutics Inc. | 11.9 Million USD | -5592.987% |
| Bio-Techne Corporation | 563.03 Million USD | -20.394% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -65.816% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -152.223% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -412.458% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -4603.796% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -314.099% |
| Nkarta, Inc. | 131.65 Million USD | -414.899% |
| BioCardia, Inc. | 12.12 Million USD | -5492.476% |
| Iterum Therapeutics plc | 47.46 Million USD | -1328.044% |